Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 July 1989:
Vol. 245. no. 4916, pp. 417 - 420
DOI: 10.1126/science.2474201

Articles

Science, Vol 245, Issue 4916, 417-420
Copyright © 1989 by American Association for the Advancement of Science


articles

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

BA Yankner, LR Dawes, S Fisher, L Villa-Komaroff, ML Oster-Granite, and RL Neve

Department of Neurology, Harvard Medical School, Boston, MA.

Amyloid deposition in senile plaques and the cerebral vasculature is a marker of Alzheimer's disease. Whether amyloid itself contributes to the neurodegenerative process or is simply a by-product of that process is unknown. Pheochromocytoma (PC12) and fibroblast (NIH 3T3) cell lines were transfected with portions of the gene for the human amyloid precursor protein. Stable PC12 cell transfectants expressing a specific amyloid-containing fragment of the precursor protein gradually degenerated when induced to differentiate into neuronal cells with nerve growth factor. Conditioned medium from these cells was toxic to neurons in primary hippocampal cultures, and the toxic agent could be removed by immunoabsorption with an antibody directed against the amyloid polypeptide. Thus, a peptide derived from the amyloid precursor may be neurotoxic.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Amyloid-{beta} Peptide (A{beta}) Neurotoxicity Is Modulated by the Rate of Peptide Aggregation: A{beta} Dimers and Trimers Correlate with Neurotoxicity.
L. W. Hung, G. D. Ciccotosto, E. Giannakis, D. J. Tew, K. Perez, C. L. Masters, R. Cappai, J. D. Wade, and K. J. Barnham (2008)
J. Neurosci. 28, 11950-11958
   Abstract »    Full Text »    PDF »
Loss of {gamma}-Secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis.
I. Y. Tamboli, K. Prager, D. R. Thal, K. M. Thelen, I. Dewachter, C. U. Pietrzik, P. St. George-Hyslop, S. S. Sisodia, B. De Strooper, M. T. Heneka, et al. (2008)
J. Neurosci. 28, 12097-12106
   Abstract »    Full Text »    PDF »
Identification of Small Molecule Inhibitors of {beta}-Amyloid Cytotoxicity through a Cell-Based High-Throughput Screening Platform.
K.I. Seyb, E.R. Schuman, J. Ni, M.M. Huang, M.L. Michaelis, and M.A. Glicksman (2008)
J Biomol Screen 13, 870-878
   Abstract »    PDF »
Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms.
S. Mulugeta, J. A. Maguire, J. L. Newitt, S. J. Russo, A. Kotorashvili, and M. F. Beers (2007)
Am J Physiol Lung Cell Mol Physiol 293, L720-L729
   Abstract »    Full Text »    PDF »
Alzheimer's-Type Amyloidosis in Transgenic Mice Impairs Survival of Newborn Neurons Derived from Adult Hippocampal Neurogenesis.
L. Verret, J. L. Jankowsky, G. M. Xu, D. R. Borchelt, and C. Rampon (2007)
J. Neurosci. 27, 6771-6780
   Abstract »    Full Text »    PDF »
Apoptosis Signal-Regulating Kinase 1 in Amyloid {beta} Peptide-Induced Cerebral Endothelial Cell Apoptosis.
M.-J. Hsu, C. Y. Hsu, B.-C. Chen, M.-C. Chen, G. Ou, and C.-H. Lin (2007)
J. Neurosci. 27, 5719-5729
   Abstract »    Full Text »    PDF »
Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death..
K.-J. Yin, C. Y. Hsu, X.-Y. Hu, H. Chen, S.-W. Chen, J. Xu, and J.-M. Lee (2006)
J. Neurosci. 26, 2290-2299
   Abstract »    Full Text »    PDF »
Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
K. P. Townsend and D. Pratico (2005)
FASEB J 19, 1592-1601
   Abstract »    Full Text »    PDF »
Amyloid {beta}-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis.
U. Keil, A. Bonert, C. A. Marques, I. Scherping, J. Weyermann, J. B. Strosznajder, F. Muller-Spahn, C. Haass, C. Czech, L. Pradier, et al. (2004)
J. Biol. Chem. 279, 50310-50320
   Abstract »    Full Text »    PDF »
Caspase-Mediated Degeneration in Alzheimer's Disease.
D. H. Cribbs, W. W. Poon, R. A. Rissman, and M. Blurton-Jones (2004)
Am. J. Pathol. 165, 353-355
   Full Text »    PDF »
Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A{beta}-induced cell death.
J. Hitomi, T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. Manabe, S. Yamagishi, Y. Bando, K. Imaizumi, et al. (2004)
J. Cell Biol. 165, 347-356
   Abstract »    Full Text »    PDF »
Oligomerization of Alzheimer's {beta}-Amyloid within Processes and Synapses of Cultured Neurons and Brain.
R. H. Takahashi, C. G. Almeida, P. F. Kearney, F. Yu, M. T. Lin, T. A. Milner, and G. K. Gouras (2004)
J. Neurosci. 24, 3592-3599
   Abstract »    Full Text »    PDF »
Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early {beta}-Amyloid Accumulation.
Z. Suo, M. Wu, B. A. Citron, G. T. Wong, and B. W. Festoff (2004)
J. Neurosci. 24, 3444-3452
   Abstract »    Full Text »    PDF »
Intracellular Accumulation of Amyloidogenic Fragments of Amyloid-{beta} Precursor Protein in Neurons with Niemann-Pick Type C Defects Is Associated with Endosomal Abnormalities.
L.-W. Jin, I. Maezawa, I. Vincent, and T. Bird (2004)
Am. J. Pathol. 164, 975-985
   Abstract »    Full Text »    PDF »
Amyloid-{beta} peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.
J.-T. Lee, J. Xu, J.-M. Lee, G. Ku, X. Han, D.-I Yang, S. Chen, and C. Y. Hsu (2004)
J. Cell Biol. 164, 123-131
   Abstract »    Full Text »    PDF »
Activation of Muscarinic Receptors Inhibits beta -Amyloid Peptide-induced Signaling in Cortical Slices.
Z. Gu, P. Zhong, and Z. Yan (2003)
J. Biol. Chem. 278, 17546-17556
   Abstract »    Full Text »    PDF »
Amyloid-beta Induces Smac Release via AP-1/Bim Activation in Cerebral Endothelial Cells.
K. J. Yin, J.-M. Lee, S. D. Chen, J. Xu, and C. Y. Hsu (2002)
J. Neurosci. 22, 9764-9770
   Abstract »    Full Text »    PDF »
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease.
Y.-H. Suh and F. Checler (2002)
Pharmacol. Rev. 54, 469-525
   Abstract »    Full Text »    PDF »
Differential Roles of JIP Scaffold Proteins in the Modulation of Amyloid Precursor Protein Metabolism.
H. Taru, Y. Kirino, and T. Suzuki (2002)
J. Biol. Chem. 277, 27567-27574
   Abstract »    Full Text »    PDF »
Apolipoprotein E4 Potentiates Amyloid beta Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells.
Z.-S. Ji, R. D. Miranda, Y. M. Newhouse, K. H. Weisgraber, Y. Huang, and R. W. Mahley (2002)
J. Biol. Chem. 277, 21821-21828
   Abstract »    Full Text »    PDF »
Carboxyl-terminal Peptide of beta -Amyloid Precursor Protein Blocks Inositol 1,4,5-Trisphosphate-sensitive Ca2+ Release in Xenopus laevis Oocytes.
J.-H. Kim, J.-C. Rah, S. P. Fraser, K.-A Chang, M. B. A. Djamgoz, and Y.-H. Suh (2002)
J. Biol. Chem. 277, 20256-20263
   Abstract »    Full Text »    PDF »
Reduced levels of amyloid {beta}-peptide antibody in Alzheimer disease.
Y. Du, R. Dodel, H. Hampel, K. Buerger, S. Lin, B. Eastwood, K. Bales, F. Gao, H.-J. Moeller, W. Oertel, et al. (2001)
Neurology 57, 801-805
   Abstract »    Full Text »    PDF »
Inflammatory Genes Are Upregulated in Expanded Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains.
B. O. Evert, I. R. Vogt, C. Kindermann, L. Ozimek, R. A. I. de Vos, E. R. P. Brunt, I. Schmitt, T. Klockgether, and U. Wullner (2001)
J. Neurosci. 21, 5389-5396
   Abstract »    Full Text »    PDF »
Immunization with a Nontoxic/Nonfibrillar Amyloid-{beta} Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice.
E. M. Sigurdsson, H. Scholtzova, P. D. Mehta, B. Frangione, and T. Wisniewski (2001)
Am. J. Pathol. 159, 439-447
   Abstract »    Full Text »
BACE knockout mice are healthy despite lacking the primary {beta}-secretase activity in brain: implications for Alzheimer's disease therapeutics.
S. L. Roberds, J. Anderson, G. Basi, M. J. Bienkowski, D. G. Branstetter, K. S. Chen, S. Freedman, N. L. Frigon, D. Games, K. Hu, et al. (2001)
Hum. Mol. Genet. 10, 1317-1324
   Abstract »    Full Text »    PDF »
Selective and Protracted Apoptosis in Human Primary Neurons Microinjected with Active Caspase-3, -6, -7, and -8.
Y. Zhang, C. Goodyer, and A. LeBlanc (2000)
J. Neurosci. 20, 8384-8389
   Abstract »    Full Text »    PDF »
Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease.
S. A. FARBER, B. E. SLACK, and J. K. BLUSZTAJN (2000)
FASEB J 14, 2198-2206
   Abstract »    Full Text »
Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity.
H.-S. KIM, C. H. PARK, S. H. CHA, J.-H. LEE, S. LEE, Y. KIM, J.-C. RAH, S.-J. JEONG, and Y.-H. SUH (2000)
FASEB J 14, 1508-1517
   Abstract »    Full Text »
High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation.
L. Mucke, E. Masliah, G.-Q. Yu, M. Mallory, E. M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue (2000)
J. Neurosci. 20, 4050-4058
   Abstract »    Full Text »    PDF »
A ßPP Peptide Carboxyl-Terminal to Aß Is Neurotoxic.
G. Marcon, G. Giaccone, B. Canciani, L. Cajola, G. Rossi, L. De Gioia, M. Salmona, O. Bugiani, and F. Tagliavini (1999)
Am. J. Pathol. 154, 1001-1007
   Abstract »    Full Text »    PDF »
Binding and Selective Detection of the Secretory N-terminal Domain of the Alzheimer Amyloid Precursor Protein on Cell Surfaces.
J. Hoffmann, C. U. Pietrzik, M. P. Kummer, C. Twiesselmann, C. Bauer, and V. Herzog (1999)
J. Histochem. Cytochem. 47, 373-382
   Abstract »    Full Text »
Transgenic Mice Over-Expressing the C-99 Fragment of ßPP with an {alpha}-Secretase Site Mutation Develop a Myopathy Similar to Human Inclusion Body Myositis.
L.-W. Jin, M. G. Hearn, C. E. Ogburn, N. Dang, D. Nochlin, W. C. Ladiges, and G. M. Martin (1998)
Am. J. Pathol. 153, 1679-1686
   Abstract »    Full Text »    PDF »
A Novel, Synergistic Interaction Between 17 beta -Estradiol and Glutathione in the Protection of Neurons against beta -Amyloid 25-35-Induced Toxicity In Vitro.
K. E. Gridley, P. S. Green, and J. W. Simpkins (1998)
Mol. Pharmacol. 54, 874-880
   Abstract »    Full Text »
The Neuronal Growth-Associated Protein GAP-43 Interacts with Rabaptin-5 and Participates in Endocytosis.
R. L. Neve, R. Coopersmith, D. L. McPhie, C. Santeufemio, K. G. Pratt, C. J. Murphy, and S. D. Lynn (1998)
J. Neurosci. 18, 7757-7767
   Abstract »    Full Text »    PDF »
Survival of Cultured Neurons from Amyloid Precursor Protein Knock-Out Mice against Alzheimer's Amyloid-beta Toxicity and Oxidative Stress.
A. R. White, H. Zheng, D. Galatis, F. Maher, L. Hesse, G. Multhaup, K. Beyreuther, C. L. Masters, and R. Cappai (1998)
J. Neurosci. 18, 6207-6217
   Abstract »    Full Text »    PDF »
Stable Complexes Involving Acetylcholinesterase and Amyloid-beta Peptide Change the Biochemical Properties of the Enzyme and Increase the Neurotoxicity of Alzheimer's Fibrils.
A. Alvarez, R. Alarcon, C. Opazo, E. O. Campos, F. J. Munoz, F. H. Calderon, F. Dajas, M. K. Gentry, B. P. Doctor, F. G. De Mello, et al. (1998)
J. Neurosci. 18, 3213-3223
   Abstract »    Full Text »    PDF »
Protein Kinase C Activation Increases Release of Secreted Amyloid Precursor Protein without Decreasing Abeta Production in Human Primary Neuron Cultures..
A. C. LeBlanc, M. Koutroumanis, and C. G. Goodyer (1998)
J. Neurosci. 18, 2907-2913
   Abstract »    Full Text »    PDF »
Neuronal Expression of beta -Amyloid Precursor Protein Alzheimer Mutations Causes Intracellular Accumulation of a C-terminal Fragment Containing Both the Amyloid beta  and Cytoplasmic Domains.
D. L. McPhie, R. K. K. Lee, C. B. Eckman, D. H. Olstein, S. P. Durham, D. Yager, S. G. Younkin, R. J. Wurtman, and R. L. Neve (1997)
J. Biol. Chem. 272, 24743-24746
   Abstract »    Full Text »    PDF »
Evidence that the 42- and 40-amino acid forms of amyloid beta  protein are generated from the beta -amyloid precursor protein by different protease activities.
M. Citron, T. S. Diehl, G. Gordon, A. L. Biere, P. Seubert, and D. J. Selkoe (1996)
PNAS 93, 13170-13175
   Abstract »    Full Text »    PDF »
Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein.
M. L. Oster-Granite, D. L. McPhie, J. Greenan, and R. L. Neve (1996)
J. Neurosci. 16, 6732-6741
   Abstract »    Full Text »    PDF »
Low Blood Pressure in Down's Syndrome: A Link With Alzheimer's Disease?.
R. A. Morrison, A. McGrath, G. Davidson, J. J. Brown, G. D. Murray, and A. F. Lever (1996)
Hypertension 28, 569-575
   Abstract »    Full Text »
Intracellular A[IMAGE]1-42 Aggregates Stimulate the Accumulation of Stable, Insoluble Amyloidogenic Fragments of the Amyloid Precursor Protein in Transfected Cells.
A. J. Yang, M. Knauer, D. A. Burdick, and C. Glabe (1995)
J. Biol. Chem. 270, 14786-14792
   Abstract »    Full Text »    PDF »
The treatment of Alzheimer's disease.
N.H.P. Allen and A. Burns (1995)
J Psychopharmacol 9, 43-56
   PDF »
Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels.
R Etcheberrigaray, E Ito, C. Kim, and D. Alkon (1994)
Science 264, 276-279
   Abstract »    PDF »
Alzheimer's disease: the amyloid cascade hypothesis.
J. Hardy and G. Higgins (1992)
Science 256, 184-185
   PDF »
Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.
S Estus, T. Golde, T Kunishita, D Blades, D Lowery, M Eisen, M Usiak, X. Qu, T Tabira, B. Greenberg, et al. (1992)
Science 255, 726-728
   Abstract »    PDF »
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.
B. Yankner, L. Duffy, and D. Kirschner (1990)
Science 250, 279-282
   Abstract »    PDF »
A Novel gamma -Secretase Assay Based on Detection of the Putative C-terminal Fragment-gamma of Amyloid beta Protein Precursor.
I. Pinnix, U. Musunuru, H. Tun, A. Sridharan, T. Golde, C. Eckman, C. Ziani-Cherif, L. Onstead, and K. Sambamurti (2001)
J. Biol. Chem. 276, 481-487
   Abstract »    Full Text »    PDF »
Effects of the beta -Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-alpha and Matrix Metalloproteinase-9 by Human Monocytic THP-1.
Y. H. Chong, J. H. Sung, S. A. Shin, J.-H. Chung, and Y.-H. Suh (2001)
J. Biol. Chem. 276, 23511-23517
   Abstract »    Full Text »    PDF »
Amyloid-{beta} Peptides Are Cytotoxic to Oligodendrocytes.
J. Xu, S. Chen, S. H. Ahmed, H. Chen, G. Ku, M. P. Goldberg, and C. Y. Hsu (2001)
J. Neurosci. 21, RC118
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)